NMR studies of SARS-CoV-2 accessory proteins

  • Funded by Swiss National Science Foundation (SNSF)
  • Total publications:3 publications

Grant number: 196256

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2023
  • Known Financial Commitments (USD)

    $499,753.78
  • Funder

    Swiss National Science Foundation (SNSF)
  • Principal Investigator

    Meier Beat H
  • Research Location

    Switzerland
  • Lead Research Institution

    Laboratorium für Physikalische Chemie D-CHAB ETH Zürich
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Form and function are one, and deciphering structure provides the fundamentals to interfere with function, as central in the context of infection. We here propose to reveal the structures of a group of proteins which the SARS-CoV-2 virus, causing the current pandemic, carries on a non-essential basis, hence their name: accessory proteins. We concentrate on these proteins for two reasons. First, and most importantly, a significant body of evidence has accumulated that points an accusing finger to the accessory proteins and their contribution to viral fitness through modulating the host response to virus infection. Them being the most varying elements in coronaviruses supports this role, since SARS-CoV-2 carries accessory proteins not observed in other human viruses before. Second, the large majority of accessory proteins are small, and often membrane-interacting. NMR is here the method of choice, and notably solid-state NMR. We will combine NMR with cell-free synthesis of the protein samples, an approach which has the central advantages of producing even complex proteins often in well-folded form, and to allow for fast screening of candidate proteins and conditions. Analysis of the samples is enabled by highest magnetic fields and most recent NMR methodology allowing to analyze as few as 100 micrograms of protein, compatible with the quantities obtained from cell-free synthesis. The two PIs on this proposal have a long-standing collaboration (85 common papers), and are strongly committed since several years to this new approach, particularly also through A. Böckmann being a guest scientist at ETH (2020-2023). They plan to apply it here to SARS-CoV-2 accessory proteins to contribute in the fight against this emerging pathogen.

Publicationslinked via Europe PMC

Last Updated:39 minutes ago

View all publications at Europe PMC

Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.

Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications.

SARS-CoV-2 ORF7b: is a bat virus protein homologue a major cause of COVID-19 symptoms?